Global Antiemetic Drug Market 2017-2021

制吐薬の世界市場2017-2021

◆タイトル:Global Antiemetic Drug Market 2017-2021
◆商品コード:IRTNTR13557
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年6月14日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、制吐薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、制吐薬の世界市場規模及び予測、用途別分析、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Antiemetic DrugEmesis is defined as forceful expulsion of stomach content either due to humoral stimulation due to chemoreceptor trigger zone (CRTZ) or neural stimulation of emetic centers. The various drugs that are used to treat this condition of emesis are known as antiemetics. The various classes of drug available for management of emesis are serotonin antagonist, dopamine antagonist, NK1 receptor antagonist, antihistaminic, steroids, and anticholinergic. The various applications of antiemetic drugs include chemotherapy, surgery, gastroenteritis, morning sickness, motion sickness, stress-induced emesis, and drugs-induced emesis. This market is primarily volume driven as majority of drugs are available in generic form.

Technavio’s analysts forecast the global antiemetic drug market to grow at a CAGR of 6.13% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global antiemetic drug market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Antiemetic Drug Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer
• Sanofi

[Other prominent vendors]
• Abbott
• Bristol-Myers Squibb
• Cipla
• Eisai
• Eli Lilly
• Glenmark
• Helsinn Healthcare
• Heron Therapeutics
• IPCA Laboratories
• Lupin
• Merck
• Novartis
• RedHill
• Sun Pharmaceutical Industries
• Takeda Pharmaceutical

[Market driver]
• Increased prevalence of cancer
• For a full, detailed list, view our report

[Market challenge]
• Lack of animal models
• For a full, detailed list, view our report

[Market trend]
• Inorganic growth strategies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: An overview of emesis

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by application
• Chemotherapy
• Surgery
• Gastroenteritis
• Others

PART 09: Market segmentation by drug class
• 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist
• Dopamine antagonist
• Neurokinin-1 (NK 1) receptor antagonist
• Cannabinoid receptor antagonist
• Others

PART 10: Geographical segmentation
• Antiemetic drug market in Americas
• Antiemetic drug market in EMEA
• Antiemetic drug market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Market challenges

PART 13: Market trends
• Inorganic growth strategies
• Guidelines for CINV drug development
• Antiemetic oral soluble films

PART 14: Vendor landscape
• Competitive scenario

PART 15: Key vendor analysis
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer
• Sanofi
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits] 
Exhibit 01: Application of antiemetic drugs
Exhibit 02: Major antiemetic drug class
Exhibit 03: Global antiemetic drugs market snapshot 2016
Exhibit 04: Steps involved in emesis
Exhibit 05: Mechanism of emesis
Exhibit 06: Causes of emesis
Exhibit 07: Global antiemetic drug market snapshot
Exhibit 08: Global antiemetic drugs market 2016-2021 ($ millions)
Exhibit 09: Opportunity analysis in global antiemetic drugs market
Exhibit 10: Five forces analysis
Exhibit 11: Pipeline analysis of vendors in Phase I
Exhibit 12: Pipeline analysis of vendors in Phase II
Exhibit 13: Pipeline analysis of vendors in Phase III
Exhibit 14: Key clinical trials
Exhibit 15: Market segmentation by application 2016
Exhibit 16: Global antiemetic chemotherapeutic drugs market 2016-2021 ($ millions)
Exhibit 17: Global antiemetic surgery treatment market 2016-2021 ($ millions)
Exhibit 18: Global antiemetic gastroenteritis drugs market 2016-2021 ($ millions)
Exhibit 19: Various emetics symptoms
Exhibit 20: Global antiemetic other drugs market 2016-2021 ($ millions)
Exhibit 21: Segmentation of global antiemetic drugs market by drug class 2016
Exhibit 22: Other drug classes of antiemetic drugs market
Exhibit 23: Segmentation of global antiemetic drugs market by geography 2016 and 2021
Exhibit 24: Segmentation of global antiemetic drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 25: Market scenario in Americas
Exhibit 26: Antiemetic drugs market in Americas 2016-2021 ($ millions)
Exhibit 27: Market scenario in EMEA
Exhibit 28: Antiemetic drugs market in EMEA 2016-2021 ($ millions)
Exhibit 29: Market scenario in APAC
Exhibit 30: Antiemetic drugs market in APAC 2016-2021 ($ millions)
Exhibit 31: Factors causing PONV
Exhibit 32: Triggers and therapeutics for CINV
Exhibit 33: Revenue of Kytril marketed by F. Hoffmann-La Roche 2014-2016 ($ millions)
Exhibit 34: Competitive structure analysis of global antiemetic drug market 2016
Exhibit 35: Competitive factors of global antiemetic drugs market
Exhibit 36: Market penetration of various global antiemetic drugs manufacturers 2016
Exhibit 37: Strategic success factors of companies in global antiemetic drugs market
Exhibit 38: GSK: Key highlights
Exhibit 39: GlaxoSmithKline: Strength assessment
Exhibit 40: GlaxoSmithKline: Strategy assessment
Exhibit 41: GlaxoSmithKline: Opportunity assessment
Exhibit 42: Johnson & Johnson: Key highlights
Exhibit 43: Johnson & Johnson: Strength assessment
Exhibit 44: Johnson & Johnson: Strategy assessment
Exhibit 45: Johnson & Johnson: Opportunity assessment
Exhibit 46: Pfizer: Key highlights
Exhibit 47: Pfizer: Strength assessment
Exhibit 48: Pfizer: Strategy assessment
Exhibit 49: Pfizer: Opportunity assessment
Exhibit 50: Sanofi: Key highlights
Exhibit 51: Sanofi: Strength assessment
Exhibit 52: Sanofi: Strategy assessment
Exhibit 53: Sanofi opportunity assessment



【掲載企業】

GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, bbott, Bristol-Myers Squibb, Cipla, Eisai, Eli Lilly, Glenmark, Helsinn Healthcare, Heron Therapeutics, IPCA Laboratories, Lupin, Merck, Novartis, RedHill, Sun Pharmaceutical Industries, and Takeda Pharmaceutical.

【資料のキーワード】

制吐薬、吐き気止め

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[制吐薬の世界市場2017-2021] (Global Antiemetic Drug Market 2017-2021 / IRTNTR13557)販売に関する免責事項
[制吐薬の世界市場2017-2021] (Global Antiemetic Drug Market 2017-2021 / IRTNTR13557)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆